Vizgen Unveils MERSCOPE Ultra™ Platform
Vizgen, Inc., an innovative life science company focused on enhancing human health through advanced technologies, has made an exciting announcement. The firm recently commenced global shipments of its eagerly awaited MERSCOPE Ultra™ Platform. This milestone marks a significant advancement in spatial genomics, allowing leading research institutions around the world to access this state-of-the-art technology.
Importance of MERSCOPE Ultra™
The MERSCOPE Ultra™ Platform builds upon the success of Vizgen’s earlier MERSCOPE Platform, which has played a pivotal role in pushing the boundaries of single-cell spatial genomics. With its improved capabilities, the MERSCOPE Ultra™ enables researchers to conduct high-resolution in situ analyses. This method facilitates the mapping and quantification of different RNA species across various tissue types, providing crucial insights that propel research forward.
Next-Gen Features of MERSCOPE Ultra™
A standout feature of the MERSCOPE Ultra™ is its remarkable imaging area. The new platform offers three times the imaging capacity of its predecessor, with an impressive 3.0 cm² available on a single slide. This upgrade creates new opportunities for researchers to efficiently analyze larger single samples or multiple smaller samples. Furthermore, the platform offers an adaptable design with two different flow chamber sizes, enhancing flexibility in experimental configurations.
Boosted Speed and Efficiency
The MERSCOPE Ultra™ significantly improves imaging speeds, which is essential for managing extensive sample areas and meeting modern research demands. It continues to support custom panels with up to 1000 genes, ensuring it remains a dependable resource for researchers who need both sensitivity and reproducibility in their work.
Response from Research Institutions
Leading scientific research institutions have eagerly awaited this groundbreaking platform. The Sanderson Center for Optical Experimental at the University of Massachusetts Chan Medical School was among the first to test the MERSCOPE Ultra. Dr. Christina Baer, the director at SCOPE, expressed her enthusiasm, noting that this advancement will enable her team to manage larger and more complex datasets seamlessly, paving the way for new research opportunities.
Positive Feedback from International Collaborators
At the prestigious Institut Pasteur, Mélanie Hamon, head of the Chromatin and Infection Unit, described the installation of the MERSCOPE Ultra as a crucial step for their 'ChromaBac' project. The expanded imaging area and faster processing speeds are expected to greatly enhance their research into the complex interactions between pathogens and host chromatin, providing unprecedented sensitivity in their investigations.
Future Innovations in Sight
Seth Benson, Vizgen's CFO, proudly stated that this achievement not only highlights the company's commitment to advancing spatial genomics but also lays the groundwork for future growth. Innovations like the upcoming MERFISH 2.0 chemistry are expected to complement the MERSCOPE Ultra™ capabilities, further unlocking the potential of genomic research.
About Vizgen
Leading the way in genomic innovation, Vizgen is dedicated to transforming life sciences with tools that enable single-cell spatial genomics. The company has established a reputation as a leader in this domain, consistently delivering outstanding sensitivity and accuracy. The MERSCOPE™ Platform empowers researchers in diverse fields such as oncology, immunology, and developmental biology, driving progress in drug discovery and development.
Frequently Asked Questions
What is the MERSCOPE Ultra™ Platform?
The MERSCOPE Ultra™ Platform is a sophisticated tool for single-cell spatial genomics that enables high-resolution analysis of RNA species within various tissues.
How does MERSCOPE Ultra™ differ from its predecessor?
The MERSCOPE Ultra™ offers three times the imaging area and improved imaging speeds, providing greater flexibility and efficiency for researchers.
What impact can MERSCOPE Ultra™ have on research?
This platform allows researchers to manage larger and more complex datasets, potentially leading to new insights across different scientific fields.
Which institutions are currently using MERSCOPE Ultra™?
Leading institutions, including the Institut Pasteur and the University of Massachusetts Chan Medical School, are among the first to implement the MERSCOPE Ultra™ Platform.
What future developments can we expect from Vizgen?
Vizgen plans to introduce the MERFISH 2.0 chemistry, which will enhance the MERSCOPE Ultra™ further and support groundbreaking research initiatives.
